Position in PFE
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$377,367
-$23,298 QoQ
Shares Held
13,439
-16.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SMITH CHAS P & ASSOCIATES PA CPAS holds $179,997,284 across 8 Drug Manufacturers - General names. PFE ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
251,939 | $61,583,969 | |
| 2 | MRK |
Merck & Co., Inc.
|
367,523 | $44,209,341 | |
| 3 | AMGN |
Amgen Inc
|
118,985 | $41,864,872 | |
| 4 | NVO |
Novo Nordisk A S
|
801,586 | $29,458,285 | |
| 5 | LLY |
ELI LILLY & Co
|
1,254 | $1,153,391 | |
| 6 | ABBV |
AbbVie Inc.
|
4,249 | $924,115 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
7,023 | $425,944 | |
| 8 | PFE |
Pfizer Inc
This page
|
13,439 | $377,367 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $377,367 | 13,439 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $400,665 | 16,091 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $339,470 | 13,323 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $572,500 | 23,618 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,105,736 | 43,636 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,243,089 | 46,856 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $1,693,539 | 58,519 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $1,876,926 | 67,081 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,166,969 | 78,089 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,600,917 | 90,341 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $3,629,925 | 109,434 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $4,895,789 | 133,473 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $29,699,707 | 727,934 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $36,883,884 | 719,826 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $31,297,327 | 715,204 | Shares | Sole | 2022-11-22 | |
| 2022-06-30 | $37,259,589 | 710,654 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $36,461,662 | 704,301 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $41,678,966 | 705,825 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $30,704,752 | 713,898 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $27,262,722 | 696,188 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $24,608,430 | 679,228 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $23,921,677 | 649,869 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $23,304,477 | 635,000 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $20,905,229 | 639,303 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $20,954,133 | 641,978 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||